Centene Corporation logo

Centene Corporation (CNC)

Market Closed
20 Jul, 20:00
NYSE NYSE
$
65. 84
-0.6
-0.9031%
$
33.93B Market Cap
16.46 P/E Ratio
- Div Yield
2.1M Volume
6.67 Eps
$ 66.44
Previous Close
Add Transaction
Day Range
65.84 67
Year Range
25.08 69.36
Want to track CNC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Centene Corporation Is On The Mend After A Hefty Fall (Upgrade)

Centene Corporation Is On The Mend After A Hefty Fall (Upgrade)

Centene Corporation delivered strong revenue growth in 2025, but earnings and profitability sharply deteriorated, driven by surging medical costs and adverse policy impacts. Despite a net loss of $6.67 billion in 2025, CNC management projects 2026 EPS above $1.98 and adjusted EPS above $3, with improved HBR and profitability. I upgrade CNC to a soft, speculative Buy based on management's 2026 guidance but highlight substantial uncertainty and risk from marketplace enrollment and policy shifts.

Seekingalpha | 5 months ago
Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength

Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength

CNC incurs a Q4 adjusted loss per share as medical costs spike, but revenues jump nearly 22% on strong PDP and Marketplace premium growth.

Zacks | 5 months ago
Centene Corporation (CNC) Q4 2025 Earnings Call Transcript

Centene Corporation (CNC) Q4 2025 Earnings Call Transcript

Centene Corporation (CNC) Q4 2025 Earnings Call Transcript

Seekingalpha | 5 months ago
Centene (CNC) Reports Q4 Earnings: What Key Metrics Have to Say

Centene (CNC) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Centene (CNC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 5 months ago
Centene (CNC) Reports Q4 Loss, Beats Revenue Estimates

Centene (CNC) Reports Q4 Loss, Beats Revenue Estimates

Centene (CNC) came out with a quarterly loss of $1.19 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to earnings of $0.8 per share a year ago.

Zacks | 5 months ago
Centene Reports $1 Billion Loss Amid Health Insurer Cost Issues

Centene Reports $1 Billion Loss Amid Health Insurer Cost Issues

Health insurer Centene reported a loss of more than $1 billion in the fourth quarter as the company continued to struggle with rising healthcare costs in the government-subsidized health plans it administers and sells.

Forbes | 5 months ago
Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?

Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?

CNC heads into Q4 earnings with revenue growth expected, but declining membership and higher medical costs cloud the outlook.

Zacks | 5 months ago
Centene Expands Palliative Care Access in Ohio Through Tuesday Health

Centene Expands Palliative Care Access in Ohio Through Tuesday Health

CNC teams up with Tuesday Health to expand palliative care in Ohio, blending in-person and virtual support.

Zacks | 6 months ago
CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

Centene expands its Medicaid strategy by partnering with Cityblock Health to serve 10,000 Illinois members with 24/7 wrap-around care.

Zacks | 6 months ago
Centene Jumps 16.3% in 3 Months: A Comeback or Calm Before the Storm?

Centene Jumps 16.3% in 3 Months: A Comeback or Calm Before the Storm?

CNC shares jump 16.3% in three months, but high medical costs and thin margins keep the recovery debate alive.

Zacks | 6 months ago
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026

Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026

Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.

Zacks | 7 months ago
3 HMO Stocks in Focus Despite Rising Medical Costs, Regulatory Pressures

3 HMO Stocks in Focus Despite Rising Medical Costs, Regulatory Pressures

The Medical-HMO industry pursues growth through M&A and tech innovation, aided by easing interest rates, but faces headwinds from rising medical costs, regulatory shifts and a shortage of healthcare professionals. UNH, HUM and CNC are likely to navigate industry storms.

Zacks | 7 months ago
Loading...
Load More